Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesBreastARRS: Breast RT doesn't impact presence of breast arterial calcificationsServiceIMV: PET/CT service contracts are a key aspect of system ownershipWomens ImagingARRS: Get involved with breast health advocacyCTARRS: The state of lung imagingWomens ImagingARRS: Most women under 40 have no imaging before breast cancer diagnosis